Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Hematology

Building Your Care Team & Evaluating Lab Reports

At a Glance

For idiopathic hypereosinophilic syndrome, a hematologist-led team should review persistent eosinophil counts, evidence of organ damage, heart testing, genetic markers, bone marrow findings, and T-cell studies; a specialist second opinion can help when key tests or expertise are missing.

Because Idiopathic Hypereosinophilic Syndrome (iHES) is a rare and multisystem disease, your care requires a team effort. You are the center of this team, but you need specialists who are not just experts in their own fields, but who are also talking to each other [1][2].

Building Your Multidisciplinary Team

While a hematologist usually leads the way, iHES can affect many different parts of the body at the same time.

The Core: Hematologist-Oncologist

Your hematologist is the primary “architect” of your treatment. Their role is to confirm your diagnosis, rule out blood cancers, and manage the medications that lower your eosinophil levels [1]. Because iHES is so rare, it is important to ask if your hematologist has experience with eosinophilic disorders or if they consult with a specialized center [3][4].

The Essential Partner: Cardiologist

A cardiologist (heart specialist) is an important part of your team [5]. Eosinophils can cause “silent” damage to the heart muscle that you might not feel until it is advanced [6].

  • Baseline Testing: You should have an initial heart evaluation including an ECG/EKG, a troponin blood test (which looks for heart muscle injury), and an echocardiogram [7][8].
  • Advanced Imaging: If initial tests are unclear or if you have symptoms like chest pain, a Cardiac MRI is an important detailed noninvasive test for looking for inflammation or early scarring in the heart. Referrals and MRI are prioritized based on symptoms, risk, and local expertise rather than being strictly obligatory for every patient from day one [9][10].

Supporting Specialists

Depending on your symptoms, your team may also include:

  • Pulmonologist: For lung involvement, such as chronic cough or shortness of breath [1].
  • Neurologist: To monitor for nerve damage (neuropathy) or to assess stroke risk [11].
  • Dermatologist: To manage chronic skin rashes or swelling [12].

Evaluating Your Lab Reports

To support a working diagnosis of “idiopathic” HES, your medical records should be complete and detailed. You can use the following discussion aid to review your pathology and lab reports with your doctor.

The iHES Discussion Aid

An idiopathic diagnosis is a clinical judgment made after a thorough evaluation [13][2].

Aspect of Workup What to Discuss with Your Doctor
Persistent AEC An Absolute Eosinophil Count (AEC) > 1.5 × 10^9/L that is persistent, interpreted in the context of your symptoms [13][14].
Organ Damage Objective evidence (biopsy, imaging, or specialized blood tests) that eosinophils are causing harm to at least one organ [15][16].
Negative Genetic Fusions Explicit evaluations for PDGFRA (including the FIP1L1 fusion), PDGFRB, FGFR1, and PCM1-JAK2 and other myeloid mutations [17][18].
Bone Marrow Review A report that looks at the “architecture” of your marrow and finds no definitive evidence of leukemia or other clonal blood cancers [19][20].
T-Cell Flow Cytometry A test of your T-cells (using flow cytometry and TCR clonality) to help interpret whether your high eosinophil levels are being driven by a lymphocytic variant [21][22].

The Power of a Second Opinion

If your lab reports are missing these genetic markers, or if your care team doesn’t seem familiar with HES, don’t hesitate to seek a second opinion at a “center of excellence” or a university-affiliated hospital [23][4]. In rare diseases, having a specialized hematopathologist (a doctor who specializes in diagnosing blood diseases) review your bone marrow slides can sometimes reveal details that were missed the first time [24][25]. Your health and peace of mind depend on a diagnosis that is as accurate as possible.

Common questions in this guide

Which specialists are usually involved in iHES care?
A hematologist or hematologist-oncologist usually coordinates care and manages evaluation and medicines that lower eosinophils. A cardiologist, pulmonologist, neurologist, or dermatologist may join the team based on heart, lung, nerve, or skin involvement.
What should an iHES workup show before the condition is called idiopathic?
Doctors look for a persistently high absolute eosinophil count, evidence that eosinophils have damaged an organ, and no identifiable genetic or blood-cancer cause. The review may include testing for PDGFRA, including the FIP1L1 fusion, PDGFRB, FGFR1, PCM1-JAK2, other myeloid mutations, bone marrow evaluation, and T-cell flow cytometry with T-cell receptor clonality testing.
What heart tests are important when iHES is diagnosed?
A baseline evaluation generally includes an ECG or EKG, a troponin blood test, and an echocardiogram. Cardiac MRI may be considered when initial tests are unclear or symptoms such as chest pain raise concern; it is not automatically required on day one for every patient.
When should someone with iHES seek a second opinion?
Consider a specialized eosinophilic-disorder center or university-affiliated hospital if reports lack key genetic testing or your care team has limited HES experience. A hematopathologist experienced in molecular markers can review bone marrow slides and help clarify difficult cases.
How can I prepare for visits about my iHES lab results?
Bring current pathology, genetic, and imaging reports, and keep a record of absolute eosinophil count results over time. Note your symptoms and whether they change with the count, and ask how the specialists communicate about your care.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with HES or rare eosinophilic disorders have you or this clinic managed in the past year?
  2. 2.Does our center have a relationship with a specialized eosinophilic-disorder center for second opinions or difficult cases?
  3. 3.Are the results from my bone marrow biopsy and genetic testing being reviewed by a dedicated hematopathologist with expertise in molecular markers?
  4. 4.What is my specific plan for cardiac monitoring, and can we schedule a baseline meeting with a cardiologist who has experience with Loeffler endocarditis?
  5. 5.What exact criteria are we using to define my 'organ damage'—is it based on imaging, blood markers, or symptoms?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (25)
  1. 1

    Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia.

    Zimmermann N, Wikenheiser-Brokamp KA

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2018; (121(2)):179-185 doi:10.1016/j.anai.2018.05.014.

    PMID: 29803709
  2. 2

    Eosinophilic Myocarditis.

    Cheung CC, Constantine M, Ahmadi A, et al.

    The American journal of the medical sciences 2017; (354(5)):486-492 doi:10.1016/j.amjms.2017.04.002.

    PMID: 29173361
  3. 3

    Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach.

    Caminati M, Carpagnano LF, Alberti C, et al.

    The World Allergy Organization journal 2024; (17(8)):100928 doi:10.1016/j.waojou.2024.100928.

    PMID: 39156600
  4. 4

    Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities.

    Khoury P, Roufosse F, Kuang FL, et al.

    Journal of leukocyte biology 2024; (116(2)):307-320 doi:10.1093/jleuko/qiae051.

    PMID: 38457125
  5. 5

    Hypereosinophilic syndrome: cardiac diagnosis and management.

    Mankad R, Bonnichsen C, Mankad S

    Heart (British Cardiac Society) 2016; (102(2)):100-6 doi:10.1136/heartjnl-2015-307959.

    PMID: 26567231
  6. 6

    Hypereosinophilic syndrome with Löffler endocarditis and multiple cerebral infarctions in a patient with a CLL-phenotype clonal B-cell population: a case report.

    Wang H, Zhu F, Hu H

    Frontiers in cardiovascular medicine 2026; (13()):1924869 doi:10.3389/fcvm.2026.1924869.

    PMID: 42688267
  7. 7

    Very early stage left ventricular endocardial dysfunction of patients with hypereosinophilic syndrome.

    Yamamoto T, Tanaka H, Kurimoto C, et al.

    The international journal of cardiovascular imaging 2016; (32(9)):1357-1361 doi:10.1007/s10554-016-0917-x.

    PMID: 27240601
  8. 8

    Hypereosinophilic syndrome presenting as acute ischemic stroke, myocardial infarction, and arterial involvement: A case report.

    Sun RR, Chen TZ, Meng M

    World journal of clinical cases 2022; (10(11)):3547-3552 doi:10.12998/wjcc.v10.i11.3547.

    PMID: 35582049
  9. 9

    Loeffler's Endocarditis: An Integrated Multimodality Approach.

    Polito MV, Hagendorff A, Citro R, et al.

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2020; (33(12)):1427-1441 doi:10.1016/j.echo.2020.09.002.

    PMID: 33129649
  10. 10

    Idiopathic Hypereosinophilic Syndrome: A Case Report.

    Agudo M, Santos F, Teixeira Reis A, et al.

    Cureus 2023; (15(6)):e39964 doi:10.7759/cureus.39964.

    PMID: 37416031
  11. 11

    Organ Involvement and Constitutional Symptoms in Idiopathic Hypereosinophilic Syndrome: A 72-Patient Single-Centre Cohort.

    Łacwik P, Kupryś-Lipińska I, Kucharczyk A, et al.

    Journal of clinical medicine 2026; (15(14)) doi:10.3390/jcm15145569.

    PMID: 42513483
  12. 12

    Consultation for Elevated Blood Eosinophils: Clinical Presentations, High Value Diagnostic Tests, and Treatment Options.

    Khoury P, Bochner BS

    The journal of allergy and clinical immunology. In practice 2018; (6(5)):1446-1453 doi:10.1016/j.jaip.2018.04.030.

    PMID: 30197068
  13. 13

    [Eosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis].

    Holle JU, Moosig F

    Zeitschrift fur Rheumatologie 2023; (82(4)):307-320 doi:10.1007/s00393-023-01345-2.

    PMID: 37099180
  14. 14

    Co-occurrence of Idiopathic Hypereosinophilic Syndrome in End-Stage Renal Disease Patients Undergoing Maintenance Hemodialysis.

    Elbahoty M, Elnaggar S, Soror N, et al.

    Cureus 2024; (16(2)):e53758 doi:10.7759/cureus.53758.

    PMID: 38465088
  15. 15

    Beyond eosinophil counts: organ involvement patterns across hypereosinophilic syndrome subtypes in a single-center cohort.

    Nicola S, Negrini S, Lo Sardo L, et al.

    Frontiers in immunology 2026; (17()):1933052 doi:10.3389/fimmu.2026.1933052.

    PMID: 42688361
  16. 16

    Paraneoplastic Hypereosinophilia With Multisystem Involvement as an Atypical Presentation of Lung Adenocarcinoma.

    Bravo S, Machado A, Medeiros P, et al.

    Cureus 2026; (18(8)):e114369 doi:10.7759/cureus.114369.

    PMID: 42598653
  17. 17

    Updates on eosinophilic disorders.

    Tzankov A, Reichard KK, Hasserjian RP, et al.

    Virchows Archiv : an international journal of pathology 2023; (482(1)):85-97 doi:10.1007/s00428-022-03402-8.

    PMID: 36068374
  18. 18

    The international consensus classification of eosinophilic disorders and systemic mastocytosis.

    Wang SA, Orazi A, Gotlib J, et al.

    American journal of hematology 2023; (98(8)):1286-1306 doi:10.1002/ajh.26966.

    PMID: 37283522
  19. 19

    Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.

    Wang SA, Hasserjian RP, Tam W, et al.

    Haematologica 2017; (102(8)):1352-1360 doi:10.3324/haematol.2017.165340.

    PMID: 28495918
  20. 20

    Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.

    Kelemen K, Saft L, Craig FE, et al.

    American journal of clinical pathology 2021; (155(2)):179-210 doi:10.1093/ajcp/aqaa244.

    PMID: 33367563
  21. 21

    Prevalence and spectrum of T-cell lymphoproliferative disorders in patients with Hypereosinophilia: A reference laboratory experience.

    Shi M, Rech KL, Otteson GE, et al.

    Annals of diagnostic pathology 2020; (44()):151412 doi:10.1016/j.anndiagpath.2019.151412.

    PMID: 31778950
  22. 22

    CD3-CD4+ Lymphocytic Variant Hypereosinophilic Syndrome: Diagnostic Tools Revisited.

    Carpentier C, Schandené L, Dewispelaere L, et al.

    The journal of allergy and clinical immunology. In practice 2021; (9(6)):2426-2439.e7 doi:10.1016/j.jaip.2021.01.030.

    PMID: 33545400
  23. 23

    Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort.

    Lefèvre G, Bleuse S, Puyade M, et al.

    Allergy 2025; (80(4)):1100-1110 doi:10.1111/all.16463.

    PMID: 39757773
  24. 24

    A case of hypereosinophilic syndrome with STAT5b N642H mutation.

    Ding F, Wu C, Li Y, et al.

    Oxford medical case reports 2021; (2021(1)):omaa129 doi:10.1093/omcr/omaa129.

    PMID: 33542831
  25. 25

    Coronary vasospasm in a patient with RUNX1 mutation in eosinophilic leukemia and hypereosinophilic syndrome: A case report.

    AlShamrani AA, Alqaraishi AM, Almukhlifi AS, et al.

    Journal of cardiology cases 2026; (33(4)):135-138 doi:10.1016/j.jccase.2026.01.001.

    PMID: 41994071

This page provides educational information about coordinating care and reviewing idiopathic hypereosinophilic syndrome tests; it is not medical advice. Your hematologist and other specialists must interpret your results and decide which tests or referrals are appropriate for you.

Get notified when new evidence is published on Idiopathic hypereosinophilic syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.